Article
Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma
1 Jan 2021
Abstract excerpt
Lung adenocarcinoma (LUAD) is one of the main causes of cancer deaths globally. Redox is emerging as a crucial contributor to the pathophysiology of LUAD, which can be regulated by long non-coding RNAs (lncRNAs). The aim of our research is to identify a novel redox-related lncRNA prognostic signature (redox-LPS) for better prediction of LUAD prognosis. 535 LUAD samples from The Cancer Genome Atlas (TCGA) database...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
